EDESA BIOTECH, INC. Increase (Decrease) in Inventories
EDESA BIOTECH, INC. (EDSA) reported Increase (Decrease) in Inventories of $0 for the 12-month period ending 2020-09-30, per its 10-K filed 2020-12-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2020-12-07
- EDESA BIOTECH, INC. increase (decrease) in inventories for the quarter ending 2019-03-31 was $31.89K, a 63.27% decline year-over-year.
- EDESA BIOTECH, INC. increase (decrease) in inventories for the quarter ending 2018-12-31 was -$12.19K, a 124.17% decline year-over-year.
- EDESA BIOTECH, INC. increase (decrease) in inventories for the quarter ending 2018-09-30 was -$13.23K.
- EDESA BIOTECH, INC. increase (decrease) in inventories for the quarter ending 2018-06-30 was $32.13K.
- EDESA BIOTECH, INC. increase (decrease) in inventories for fiscal 2020 was $0.00.
- EDESA BIOTECH, INC. increase (decrease) in inventories for fiscal 2018 was $0.00.
- EDESA BIOTECH, INC. increase (decrease) in inventories for fiscal 2018 was $156.15K.
- EDESA BIOTECH, INC. increase (decrease) in inventories for fiscal 2017 was -$181.32K.
| Period end | Increase (Decrease) in Inventories 1 month | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|
| 2020-09-30 | $0.00 10-K · filed 2020-12-07 | ||||
| 2019-09-30 | -$77.91K 10-K · filed 2020-12-07 | ||||
| 2019-03-31 | $31.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | $19.70K 10-Q · filed 2019-05-08 | $6.48K derived: sum of 3 quarters · filed 2019-05-08 | $38.61K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-12-31 | -$12.19K 10-Q · filed 2019-02-05 | -$25.41K derived: sum of 2 quarters · filed 2019-02-05 | $6.71K derived: sum of 3 quarters · filed 2019-02-05 | $0.00 10-KT · filed 2019-12-12 | |
| 2018-09-30 | -$13.23K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $18.90K derived: sum of 2 quarters · filed 2018-11-30 | $105.73K derived: sum of 3 quarters · filed 2019-05-08 | $156.15K 10-K · filed 2018-11-30 | |
| 2018-06-30 | $32.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | $118.95K derived: sum of 2 quarters · filed 2019-05-08 | $169.38K 10-Q · filed 2018-08-08 | $96.55K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-03-31 | $86.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | $137.25K 10-Q · filed 2019-05-08 | $64.42K derived: sum of 3 quarters · filed 2019-05-08 | -$105.21K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | $50.43K 10-Q · filed 2019-02-05 | -$22.41K derived: sum of 2 quarters · filed 2019-02-05 | -$192.03K derived: sum of 3 quarters · filed 2019-02-05 | -$211.04K derived: sum of 4 quarters · filed 2019-02-05 | |
| 2017-09-30 | -$72.83K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | -$242.46K derived: sum of 2 quarters · filed 2018-11-30 | -$261.47K derived: sum of 3 quarters · filed 2018-11-30 | -$181.32K 10-K · filed 2018-11-30 | |
| 2017-06-30 | -$169.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -$188.64K derived: sum of 2 quarters · filed 2018-08-08 | -$108.48K 10-Q · filed 2018-08-08 | -$427.75K derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | -$19.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-07 | $61.14K 10-Q · filed 2018-05-07 | -$258.12K derived: sum of 3 quarters · filed 2018-05-07 | -$232.89K derived: sum of 4 quarters · filed 2018-05-07 | |
| 2016-12-31 | $80.15K 10-Q · filed 2018-02-07 | -$239.12K derived: sum of 2 quarters · filed 2018-02-07 | -$213.88K derived: sum of 3 quarters · filed 2018-02-07 | -$198.38K derived: sum of 4 quarters · filed 2018-02-07 | |
| 2016-09-30 | -$319.27K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | -$294.03K derived: sum of 2 quarters · filed 2017-12-01 | -$278.53K derived: sum of 3 quarters · filed 2017-12-01 | -$307.85K 10-K · filed 2017-12-01 | |
| 2016-06-30 | $25.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $40.74K derived: sum of 2 quarters · filed 2017-08-09 | $11.42K 10-Q · filed 2017-08-09 | $374.33K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2016-03-31 | $15.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-09 | -$13.82K 10-Q · filed 2017-05-09 | $349.10K derived: sum of 3 quarters · filed 2017-12-01 | $408.31K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2015-12-31 | -$29.32K 10-Q · filed 2017-02-06 | $333.59K derived: sum of 2 quarters · filed 2017-12-01 | $392.81K derived: sum of 3 quarters · filed 2017-12-01 | $393.65K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2015-09-30 | $362.91K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $422.13K derived: sum of 2 quarters · filed 2017-12-01 | $422.97K derived: sum of 3 quarters · filed 2017-12-01 | $522.39K 10-K · filed 2017-12-01 | |
| 2015-06-30 | $59.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $60.06K derived: sum of 2 quarters · filed 2016-08-09 | $159.48K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $843.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | $100.26K 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $99.42K 10-Q · filed 2016-02-08 | ||||
| 2014-09-30 | $34.89K 10-K · filed 2016-12-14 | ||||
| 2014-08-31 | $0.00 10-K · filed 2016-12-14 | ||||
| 2013-12-31 | -$158.28K 10-Q · filed 2015-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |